Organometallics
ARTICLE
3368 (vs, νNH), 3166, 3144, 3061, 2977, 1702 (vs, νCO), 1493, 1446,
1365, 1252, 1168. ESI-MS (MeOH, m/z): 454 (100) [M]+. Anal. Calcd
(%) for C29H32ClN3O2: C, 71.09; H, 6.58; N, 8.58. Found: C, 71.16; H,
6.50; N, 8.65. Mp = 68 °C. Crystals of 1c suitable for single-crystal X-ray
diffraction were grown from a double layer of dichloromethane and
petroleum ether (1:4) at room temperature.
C7H2, NBD), 54.5 (CH2, CH2Ph), 51.1 (d, JC,Rh = 15.7 Hz, CH, NBD),
49.4 (d, JCꢀRh = 12.1 Hz, CH, NBD), 49.2 (NCH2), 48.6 (d, JCꢀRh
=
11.5 Hz, CH, NBD), 41.8 (CH2NH), 28.3 (CH3, tBu). IR
(CH2Cl2, cmꢀ1): 1710 (vs, νCO). IR (KBr, cmꢀ1): 3340 (s, νNH),
3167, 3123, 3091, 3060, 3032, 2978, 2928, 1708 cmꢀ1 (vs, νCO), 1509,
1365, 1250, 1173. ESI-MS (MeOH, m/z): 554 (12) [M + Na]+, 496
(100) [M ꢀ Cl]+; 530 (100) [M ꢀ H]ꢀ. Anal. Calcd (%) for
C24H31ClN3O2Rh: C, 54.19; H, 5.87; N, 7.90. Found: C, 54.21; H,
5.89; N, 7.87. Mp = 97 °C.
Preparation of [Rh(NBD)Cl{1-(2-NHBoc-ethyl)-3-R-imidazolin-2-
ylidene}], R = Me (3a), Bnz (3b), Trit (3c). Synthesis of 3a. To a
solution of 1a (0.258 g 0.73 mmol) in CH2Cl2 (ca. 30 mL) was added
Ag2O (0.107 g, 0.37 mmol). The suspension was stirred for 2 h
and filtered on Celite, and the filtrate was added to a solution of
[Rh(NBD)Cl]2 (0.168 g 0.37 mmol) in CH2Cl2. After stirring for 3 h
the yellow AgI was filtered off, and the solvent was removed under
vacuum. The crude material was purified by column chromatography on
silica gel using first CH2Cl2 and then CH2Cl2/MeOH [100:3 (v/v)] as
eluent to afford 0.23 g (71%) of 3a as a yellow solid. Rf: 0.60 (CH2Cl2/
Synthesis of 3c. To a solution of 1c (0.200 g, 0.41 mmol) in CH2Cl2
(20 mL) was added Ag2O (0.050 g, 0.21 mmol). The suspension was
stirred for 48 h, then solid [Rh(NBD)Cl]2 (0.092 g, 0.20 mmol) was
directly added to the reaction mixture. After stirring for a further 2 h the
crude material was filtered on a Celite pad, the insoluble material was
thoroughly washed with CH2Cl2, and the solvent was removed under
vacuum. The residue was purified by column chromatography on silica
gel treated with 5% v/v triethylamine in Et2O, using Et2O/CH2Cl2, 1:3
(v/v), to afford 0.22 g (78%) of 3c as a yellow solid. Rf: 0.71 (CH2Cl2/
MeOH, 100:5); Rf: 0.22 (Et2O). Suitable crystals for an X-ray diffraction
analysis were obtained from a concentrated solution of 3c in CH3CN
at ꢀ20 °C.
1
MeOH, 100:5). H NMR (300.1 MHz, CDCl3): δ 6.76 (br s, 2H,
CHim), 5.34 (br s, 1H, NH), 4.86 (m, 2H, NBD), 4.49 (m, 2H, NCH2),
4.10 (s, 3H, NCH3), 3.92 (m, 2H, CH2NH), 3.82 (m, 2H, NBD), 3.49
t
(m, 2H, NBD), 1.41 (s, 9H, Bu), 1.36 (t, 2H, JH,H = 1.4 Hz, C7H2
NBD). 13C{1H} NMR (75 MHz, CDCl3): δ 184.2 (d, JC,Rh = 57.1 Hz),
156.3 (CdO), 121.8 (CHim), 121.6 (CHim), 79.4 (d, JC,Rh = 4.6 Hz,
NBD), 79.2 (Cq, tBu), 63.6 (d, JC,Rh = 4.8 Hz; NBD), 51.0 (d, JC,Rh = 2.4
Hz, NBD), 49.6 (NCH2), 48.1 (d, JC,Rh = 12.3 Hz, NBD), 41.3
(CH2NH), 37.9 (NCH3), 28.4 (CH3, tBu). IR (CH2Cl2, cmꢀ1): 1712
(vs, νCO). IR (KBr, cmꢀ1): 3386 (s, νNH), 3156, 3120, 3104, 3056, 3041,
2981, 2922, 1700 cmꢀ1 (vs, νCO), 1500, 1364, 1254, 1173. ESI-MS
(MeOH, m/z): 478 (11) [M + Na]+, 420 (100) [M ꢀ Cl]+; 490 (100)
[M + Cl]ꢀ. Anal. Calcd (%) for C18H27ClN3O2Rh: C, 47.43; H, 5.97; N,
9.22. Found: C, 47.10; H, 6.04; N, 9.23. Mp = 136 °C (dec). Suitable
crystals of 3a for X-ray diffraction have been obtained by slow evapora-
tion from a mixture of CH2Cl2 and petroleum ether.
The silver intermediate 2c was not isolated, but a 1H NMR and ESI-
MS analysis was carried out on the crude material to confirm its
1
formation. H NMR of 2c (399.9 MHz, CDCl3): δ 7.36ꢀ7.21 (m,
15H, Ph), 7.29 (s, 1H, CHim), 7.03 (s, 1H, CHim), 4.24 (t, 2H, JH,H = 6.0
Hz, NCH2), 3.51 (t, 2H, JH,H = 6.0 Hz, CH2NH), 1.43 (s, 9H, tBu), the
NH resonance was not observed. 13C{1H} NMR (100.6 MHz, CDCl3):
δ 183.9 (s, C-Ag), 156.8 (CdO), 142.0 (C5), 130.0 (C4), 128.4 (C2,
t
C3), 123.5 (CHim), 119.5 (CHim), 80.0 (C1), 79.9 (Cq, Bu), 52.6
t
(NCH2), 41.4 (CH2NH), 28.3 (CH3, Bu). ESI-MS (MeOH, m/z):
1015 (50) [C58H64AgN6O4]+, 243 (100) [Ph3C]+.
1H NMR of 3c (599.7 MHz, CDCl3, 243.2 K): δ 7.38ꢀ7.17 (m, 15H,
Ph), 6.98 (s, 1H, CHim), 6.46 (s, 1H, CHim), 6.02 (br s, 1H, NCH2), 6.14
(t, JH,H = 5.1 Hz, 1H, NH), 4.60 (br s, 1H, NCH2), 4.53 (s, 1H, NBD),
3.88 (br s, 1H, CH2NH), 3.72 (br s, 1H, CH2NH), 3.62 (s, 1H, CH,
NBD), 3.57 (s, 1H, CH, NBD), 3.23 (s, 1H, CH, NBD), 2.82 (s, 1H,
Synthesis of 3b. To a solution of 1b (0.500 g, 1.31 mmol) in CH2Cl2
(30 mL) was added Ag2O (0.154 g, 0.66 mmol). After stirring for 2 h at
room temperature, the suspension was filtered on Celite and the filtrate
added to a solution of [Rh(NBD)Cl]2 (0.301 g, 0.65 mmol) in CH2Cl2.
After 3 h, AgBr was filtered off and the solvent was removed under
vacuum. The crude material was purified by column chromatography on
silica gel using first CH2Cl2 and then CH2Cl2/MeOH, 100:1 (v/v), as
eluent to afford 0.67 g (78%) of 3b as a yellow solid. Rf: 0.65 (CH2Cl2/
MeOH, 100:5).
t
CH, NBD), 2.1 (s, 1H, CH, NBD), 1.41 (s, 9H, Bu), 0.98 (m, 2H,
NBD). 13C{1H} NMR (150.8 MHz, CDCl3, 243.2 K): δ 185.4 (d,
JC,Rh = 56.1 Hz), 156.6 (CdO), 142.1 (C5), 128.7 (C4), 128.3 (C2),
127.4 (C3), 124.8 (CHim), 119.7 (CHim), 79.1 (Cq, tBu), 77.3 (C1), 73.5
(CH, NBD), 64.3 (CH, NBD), 61.9 (C7H2, JC,Rh = 5.1 Hz, NBD), 51.2
(NCH2), 49.3 (CH, NBD), 48.7 (CH, NBD), 45.1 (CH, NBD), 44.7
The silver intermediate of 1-(2-BocNH-ethyl)-3-benzylimidazolin-2-
ylidene, silver bromide 2b, was not isolated, but a NMR and ESI-MS
analysis was carried out on the crude material to confirm its formation.
1H NMR of 2b (399.9 MHz, CDCl3): δ 7.21ꢀ6.98 (m, 5H, Ph), 7.02 (s,
t
(CH, NBD), 40.8 (CH2NH), 28.8 (CH3, Bu). IR (CH2Cl2, cmꢀ1):
1702 (vs, νCO). IR (KBr, cmꢀ1): 3319 (s, νNH), 3141, 3089, 3058, 3032,
2975, 2930, 1707 (vs, νCO), 1492, 1445, 1250, 1170. ESI-MS (MeOH,
m/z): 648 (100) [M ꢀ Cl]+; 682 [M ꢀ H]ꢀ. Anal. Calcd (%) for
C36H39ClN3O2Rh: C, 63.21; H, 5.75; N, 6.14. Found: C, 63.51; H, 5.98;
N, 6.04. Mp = 108 °C.
1
1H, CHim), 6.81 (s, 1H, CHim), 5.74 (br s, H, NH), 5.14 (s, 2H,
PhCH2N), 4.16 (br t, 2H, NCH2), 3.39 (br t, 2H, CH2NH), 1.28 (s, 9H,
CH3). 13C{1H} NMR (100.6 MHz, CDCl3): δ 181.5 (s, C-Ag), 155.9
(CdO), 135.7 (Ph, C5); 128.7 (Ph, C4); 128.1 (Ph, C3); 127.3 (Ph, C2),
122.0 (CHim), 120.9 (CHim), 78.9 (Cq, tBu), 55.2 (CH2, PhCH2), 51.1
(CH2, NCH2), 41.2 (CH2, CH2NH), 28.1 (CH3, tBu). IR
(CH2Cl2, cmꢀ1): 1707 (vs, νCO). ESI-MS (MeOH, m/z): 709 (100)
[C34H46AgN6O4]+; 79 (100), 81 (97) [Br]ꢀ.
Synthesis of [Rh(NBD)I{1-(2-NHBoc-ethyl)-3-methylimi-
dazolin-2-ylidene}], 4a, by Method B (iii). [Rh(NBD)Cl]2
(0.050 g, 0.11 mmol) and KOtBu (0.024 g, 0.22 mmol) were reacted
in THF (10 mL) for 3 h. Successively the imidazolium salt 1a (0.076 g,
0.212 mmol) was added, and after stirring for a further 3 h the solid was
removed by filtration and the resulting orange solution was evaporated
to dryness. After washing with Et2O 0.049 g (41%) of 4a was obtained,
and suitable crystals of 4a for X-ray diffraction have been obtained by
slow evaporation from a mixture of CH2Cl2 and petroleum ether.
Synthesis of 4a by Ion Exchange. Alternatively to a solution of
3a (0.050 mg, 0.11 mmol) in degassed methanol (2 mL) was added an
excess of NaI (0.030 g, 0.2 mmol). After stirring for 20 h the suspension
was filtered, and after removal of the volatiles in vacuo the product was
used without further workup. 1H NMR (399.9 MHz, CDCl3): δ 6.78 (s,
2H, CHim), 5.25 (br s, 1H, NH), 5.09 (m, 1H, CH, NBD), 4.98 (m, 1H,
CH, NBD), 4.64 (m, 1H, NCH2), 4.26 (m, 1H, NCH2), 3.98 (s, 3H,
1H NMR of 3b (599.7 MHz, CDCl3, 228.18 K): δ 7.35 (m, 5H, Ph),
6.79 (d, 1H, JH,H = 1.8 Hz, CHim), 6.68 (d, 1H, JH,H = 1.8 Hz, CHim),
6.01 (d, 1H, JH,H = 15.2 Hz, CH2Ph), 5.57 (d, 1H, JH,H = 15.2 Hz,
CH2Ph), 5.45 (t, 1H, JH,H = 5.6 Hz, NH), 4.83 (m, 2H, NBD), 4.70 (m,
1H, NCH2); 4.31 (m, 1H, NCH2), 4.18 (m, 1H, CH2NH), 3.81 (m, 1H,
NBD), 3.76 (m, 1H, CH2NH), 3.67 (m, 1H, NBD), 3.51 (m, 1H, NBD),
3.23 (m, 1H, NBD), 1.39 (s, 9H, CH3), 1.31 (d, 1H, JH,H = 8.1 Hz, C7H2,
NBD), 1.26 (d, 1H, JH,H = 8.1 Hz, C7H2, NBD). 13C{1H} NMR (150.8
MHz, CDCl3, 228.2 K): δ 185.2 (d, JC,Rh = 55.2), 156.3 (CdO), 136.8
(Ph, C5); 128.9 (Ph, C4); 128.6 (Ph, C3); 128.1 (Ph, C2), 122.3 (CHIm),
120.5 (CHIm), 79.3 (Cq, tBu), 79.2 (CH, NBD), 63.6 (d, JC,Rh = 4.8 Hz,
5269
dx.doi.org/10.1021/om200631w |Organometallics 2011, 30, 5258–5272